Mithat Gönen

3 ta ish

Memorial Sloan Kettering Cancer Center

1. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

   Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6

   MaqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.102842

2. Assessing the Performance of Prediction Models

   Ewout W. Steyerberg, Andrew J. Vickers, Nancy R. Cook +5

   Maqola20094 iqtibos

   ABIABI:AkademIndex/2026.other.480485

3. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

   Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière +27

   MaqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.102892